Summary: Exercise of governmental authority to control conduct.
Publications237 found, 100 shown here
- Evaluation of carcinogenic hazard of diesel engine exhaust needs to consider revolutionary changes in diesel technologyRoger O McClellan
Toxicology and Risk Analysis, 13701 Quaking Aspen Place NE, Albuquerque, NM 87111, USA
Regul Toxicol Pharmacol 63:225-58. 2012..We recommend that future reviews of carcinogenic hazards of diesel exhaust evaluate NTDE separately from TDE...
- Scientific and legal perspectives on science generated for regulatory activitiesCarol J Henry
American Chemistry Council, Arlington, Virginia, USA
Environ Health Perspect 116:136-41. 2008..In a closely related example, the U.S. Environmental Protection Agency considered but abandoned a program to implement standards aimed at "external" information...
- Lead exposure, lead poisoning, and lead regulatory standards in China, 1990-2005Xibiao Ye
Fudan University School of Public Health, Shanghai, China
Regul Toxicol Pharmacol 46:157-62. 2006..The 2002 Act, without the necessary enforcement, did not appear to have a major impact on either lead exposures or lead poisoning in China. Much work in enforcing the 2002 Act remains to be done...
- Informed consent, anticipatory regulation and ethnographic practiceElizabeth Murphy
University of Nottingham, Nottingham, UK
Soc Sci Med 65:2223-34. 2007..We conclude the paper with a number of suggestions about how such professional models might be implemented...
- Tobacco: a product like any other?Kirill Danishevskiy
ATACA Anti Tobacco Advocacy Coalition, Moscow, Russia
Health Econ Policy Law 6:265-72. 2011..We argue that the only way to redress this situation is to recognize that tobacco production and sales must be regulated in the same way as any other harmful and addictive substance...
- FDA regulation of stem-cell-based therapiesDina Gould Halme
School of Medicine, University of California at San Francisco, San Francisco, USA
N Engl J Med 355:1730-5. 2006
- Ambient air pollution: health hazards to childrenJanice J Kim
Pediatrics 114:1699-707. 2004....
- A legal framework for preventing cardiovascular diseasesWendy C Perdue
Georgetown University Law Center, Washington, DC 20001, USA
Am J Prev Med 29:139-45. 2005..Examples of key roles that health professionals can play in advancing such an understanding are presented...
- Drug shop regulation and malaria treatment in Tanzania--why do shops break the rules, and does it matter?Catherine Goodman
Health Policy Unit, London School of Hygiene and Tropical Medicine, London, UK
Health Policy Plan 22:393-403. 2007..Such a change in approach has the potential to provide a firmer platform for public-private collaboration to improve shop-based treatment...
- Why do people cooperate with medical research? Findings from three studiesMary Dixon-Woods
University of Leicester, Leicester, United Kingdom
Soc Sci Med 68:2215-22. 2009..Attention to the institutional context of research is critical to understanding what makes cooperation possible, and has important implications for the design of regulatory regimes for research...
- Understanding Philip Morris's pursuit of US government regulation of tobaccoP A McDaniel
Center for Tobacco Control Research and Education, University of California, San Francisco, 530 Parnassus Avenue, Suite 366, San Francisco, CA 94143 1390, USA
Tob Control 14:193-200. 2005..To investigate Philip Morris's support of US Food and Drug Administration (FDA) regulation of tobacco products and analyse its relationship to the company's image enhancement strategies...
- Commercialism, choice and consumer protection: regulation of complementary medicines in AustraliaKen J Harvey
School of Public Health, La Trobe University, Melbourne, Vic, Australia
Med J Aust 188:21-5. 2008..Complaint procedures (now overloaded) are no substitute for adequate regulation at the time of market entry. Regulatory reform of listed and homoeopathic products is required...
- The interplay of public health law and industry self-regulation: the case of sugar-sweetened beverage sales in schoolsMichelle M Mello
Department of Health Policy and Management, Harvard School of Public Health, 677 Huntington Ave, Boston, MA 02115, USA
Am J Public Health 98:595-604. 2008....
- Choosing health? First choose your philosophyMartin McKee
Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London WC1E 7 hT, UK
Lancet 365:369-71. 2005
- The creation of industry front groups: the tobacco industry and "get government off our back"Dorie E Apollonio
Department of Clinical Pharmacy, University of California San Francisco, San Francisco, CA 94143, USA
Am J Public Health 97:419-27. 2007..Those who seek to establish measures to protect public health should be prepared to counter the argument that government should not regulate private behavior...
- Calorie labeling and food choices: a first look at the effects on low-income people in New York CityBrian Elbel
Division of General Internal Medicine at New York University School of Medicine and NYU Wagner School of Public Service, New York City, USA
Health Aff (Millwood) 28:w1110-21. 2009..However, we did not detect a change in calories purchased after the introduction of calorie labeling. We encourage more research on menu labeling and greater attention to evaluating and implementing other obesity-related policies...
- Tobacco industry manipulation of researchLisa A Bero
Department of Clinical Pharmacy, School of Pharmacy, Institute for Health Policy Studies, University of California, San Francisco 94143, USA
Public Health Rep 120:200-8. 2005
- Naturally occurring asbestos: a recurring public policy challengeR J Lee
RJ Lee Group Inc, Monroeville, PA 15146, USA
J Hazard Mater 153:1-21. 2008....
- Government regulation of sex and sexuality: in their own wordsSofia Gruskin
Department of Global Health and Population, Harvard School of Public Health, Boston, MA, USA
Reprod Health Matters 17:108-18. 2009....
- The health benefits of reduced tropospheric ozone in CaliforniaBart D Ostro
Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Oakland, CA 94612, USA
J Air Waste Manag Assoc 56:1007-21. 2006....
- Decline in hospitalisations due to dog bite injuries in Catalonia, 1997-2008. An effect of government regulation?Joan R Villalbí
Agència de Salut Pública de Barcelona, Barcelona, Spain
Inj Prev 16:408-10. 2010..To analyse population-based data on hospitalisation caused by dog bite injuries after changes in legal regulations on dog ownership, including breed-specific regulations...
- Learning the value of drugs--is rofecoxib a regulatory success story?Rebecca S Eisenberg
University of Michigan Law School, Ann Arbor, USA
N Engl J Med 352:1285-7. 2005
- Modern regulatory impact analysis: the experience of the European UnionBruce Ballantine
Business Decisions Limited, Heronswood House, Maidstone Road, Pembury, Kent TN2 4DD, UK
Regul Toxicol Pharmacol 44:57-68. 2006..The paper finally draws a number of conclusions and makes a number of recommendations for further improvements in the quality of the regulatory process in the European Union...
- The birth of the e-clinic. Continuity or transformation in the UK governance of pharmaceutical consumption?Nick Fox
ScHARR, University of Sheffield, Regent Court, 30 Regent Street, Sheffield S1 4DA, UK
Soc Sci Med 61:1474-84. 2005..This continuity can be explained by Rosenau's (Along the Domestic-Foreign Frontier. Cambridge University Press, Cambridge, 1997) model of a contested and fragmenting process of technology governance...
- Manufacturing uncertainty: contested science and the protection of the public's health and environmentDavid Michaels
Department of Environmental and Occupational Health, George Washington University School of Public Health and Health Services, 2100 M St NW, Suite 203, Washington, DC 20037, USA
Am J Public Health 95:S39-48. 2005..The public health system must ensure that scientific evidence is evaluated in a manner that assures the public's health and environment will be adequately protected...
- Regulatory parallels to Daubert: stakeholder influence, "sound science," and the delayed adoption of health-protective standardsRoni A Neff
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Room E6636, Baltimore, MD 21205, USA
Am J Public Health 95:S81-91. 2005..Most recently, political tampering with science provides the foundation for some policymakers to disregard science completely in the environmental regulatory process...
- Organophosphate exposures in the United States: a longitudinal analysis of incidents reported to poison centersDaniel L Sudakin
Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, Oregon 97331 6502, USA
J Toxicol Environ Health A 70:141-7. 2007..The results of this investigation are consistent with other studies that have reported that regulatory restriction of access to pesticide formulations may have a significant impact on the number of human exposure incidents...
- Environmental pediatrics and its impact on government health policyLynn Goldman
Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 20815, USA
Pediatrics 113:1146-57. 2004..More recently, these issues have been taken up by states and in the international arena...
- European Clinical Trials Directive: responses made to MHRA consultation letter MLX 287David J Flavell
Lancet 362:1415. 2003
- Perspectives on human stem cell researchKyu Won Jung
Law School, Hanyang University, 17 Haengdang dong, Seongdong Gu, Seoul 133 791, South Korea
J Cell Physiol 220:535-7. 2009..We do not need to exclude any type of stem cell research because each has its own merits and issues, and they can facilitate the scientific revolution when working together...
- Perceived justice and popular support for public health laws: a case study around comprehensive smoke-free legislation in Mexico CityJames F Thrasher
Department of Health Promotion, Education and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA
Soc Sci Med 70:787-93. 2010....
- The unintended consequences of clinical trials regulationsAlex D McMahon
Dental School, Faculty of Medicine, University of Glasgow, Glasgow, Scotland
PLoS Med 3:e1000131. 2009..Alex McMahon and colleagues critique the International Conference on Harmonisation (ICH) guidance on good clinical practice (GCP), arguing that it is having a disastrous effect on noncommerical randomized clinical trials in Europe...
- Legislating "sound science": the role of the tobacco industryAnnamaria Baba
Department of Clinical Pharmacy, University of California, San Francisco, 3333 California Street, Suite 420, Box 0613, San Francisco, CA 94143, USA
Am J Public Health 95:S20-7. 2005..The tobacco industry played a role in establishing laws that increase corporate influence on public health and regulatory policy decisions...
- Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settingsGiuliano Russo
Instituto de Higiene e Medicina Tropical, Rua da Junqueira 96, 1349 008 Lisbon, Portugal
Health Policy Plan 25:70-84. 2010..We also argue that price controls may not be the most effective way to influence access to medicines in low-income countries, and managing demand and supply towards cheaper effective drugs appears a more suitable policy option...
- Child care as an untapped setting for obesity prevention: state child care licensing regulations related to nutrition, physical activity, and media use for preschool-aged children in the United StatesKaren M Kaphingst
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 S 2nd St, Ste 300, Minneapolis, MN 55454, USA
Prev Chronic Dis 6:A11. 2009..6 million preschool-aged children participated in child care in 2001. Each US state creates and enforces its own child care licensing regulations. We analyzed obesity-related child care licensing regulations of US states...
- Declining sex ratio: role of society, technology and government regulation in Faridabad district, HaryanaA Bardia
Centre for Community Medicine, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India
Natl Med J India 17:207-11. 2004..a male child, awareness and acceptability of the practice of sex determination), technology (availability and affordability) and government regulation in the adverse ratio for girls in the Ballabgarh block of Haryana in northern India.
- A regulatory patchwork--human ES cell research oversightLori P Knowles
Health Law Institute, University of Alberta, Canada
Nat Biotechnol 22:157-63. 2004
- Unregulated private markets for health care in Canada? Rules of professional misconduct, physician kickbacks and physician self-referralSujit Choudhry
Faculty of Law, University of Toronto, ON
CMAJ 170:1115-8. 2004
- Ethics and policy perspectives on personalized medicine in the post-genomic eraMelissa R Landon
Boston University, USA
J Biolaw Bus 8:28-36. 2005....
- Philip Morris' FDA gambit: good for public health?Michael Givel
Department of Political Science, The University of Oklahoma, 455 West Lindsey, Room 2I7, Norman, USA
J Public Health Policy 26:450-68. 2005..On the other hand, tobacco products would have remained a politically and economically viable and legal product consumed by millions of Americans many of whom would have continued to suffer from tobacco-related illnesses and deaths...
- Human research protections: time for regulatory reform?Karen J Maschke
Hastings Cent Rep 38:19-22. 2008
- The first pharmacoepidemiologic investigations: national drug safety policy in the United States, 1901-1902David E Lilienfeld
Perspect Biol Med 51:188-98. 2008..That power, welcomed by manufacturers to restore the public's trust in their products, was enhanced in the 1906 Food and Drug Act, which created the Food and Drug Administration...
- The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'ReillyDavid C Vladeck
Georgetown University Law Center Center of Health Regulation and Governance of the O Neill Institute for National and Global Health Law Institute for Public Representation and Center for Progressive Reform, USA
Cornell Law Rev 93:981-1002. 2008
- Daubert's menaceGio Batta Gori
Am J Public Health 96:206; discussion 206-7. 2006
- New federal guidelines for physician-pharmaceutical industry relations: the politics of policy formationSusan Chimonas
Center on Medicine as a Profession CMAP, College of Physicians and Surgeons, Columbia University, New York, NY, USA
Health Aff (Millwood) 24:949-60. 2005..We also explore the implications--some intended, others unanticipated--of the final document...
- The impact of the cox-2 inhibitor issue on perceptions of the pharmaceutical industry: content analysis and communication implicationsRagnar E Lofstedt
King s Centre for Risk Management, King s College London, London, England
J Health Commun 12:471-91. 2007....
- Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefitDavid Wendler
Department of Clinical Bioethics, NIH Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA
JAMA 294:826-32. 2005..These data also raise the question of whether the federal minimal risk standard may sometimes fail to provide sufficient protection for children, prompting the need to consider alternative standards...
- The perils of relying on interested parties to evaluate scientific qualityWendy Wagner
University of Texas School of Law, 727 East Dean Keeton Street, Austin, TX 78705 3299, USA
Am J Public Health 95:S99-106. 2005....
- Neoliberal and public health effects of failing to adopt OSHA's national secondhand tobacco smoke ruleMichael Givel
Department of Political Science, The University of Oklahoma, Norman 73109, USA
Int J Health Serv 36:137-55. 2006....
- Rights, patents, markets and the global AIDS pandemicJames Thuo Gathii
Albany Law School, USA
Fla J Int Law 14:261-352. 2002
- From Asilomar to industrial biotechnology: risks, reductionism and regulationSheldon Krimsky
Department of Urban and Environmental Policy and Planning, Tufts University, Medford, MA 02155, USA
Sci Cult (Lond) 14:309-23. 2005
- Legal developments relevant to FDA authorityDaniel Meron
Department of Health and Human Services, USA
Food Drug Law J 62:441-4. 2007
- The case for preemption of prescription drug failure-to-warn claimsChristine H Kim
Food Drug Law J 62:399-422. 2007
- Diversionary reframing of the Great Lakes Water Quality AgreementMichael Gilbertson
Occupational and Environmental Health Research Group, Stirling University, Scotland, UK
J Public Health Policy 28:201-15. 2007..The scientific evidence of continuing injury to health and property from trans-boundary pollution convinces us that this reframing is an unwarranted diversion from the original intent...
- Drug risks and free speech--can Congress ban consumer drug ads?Miriam Shuchman
N Engl J Med 356:2236-9. 2007
- Death at a discount: how the tobacco industry thwarted tobacco control policies in US military commissariesElizabeth A Smith
Department of Social and Behavioral Sciences, University of California, San Francisco, Box 0612 San Francisco, CA 94143 0612, USA
Tob Control 16:38-46. 2007..Tobacco use also impairs short-term troop readiness...
- Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debateHoward L Dorfman
Bayer HealthCare LLC, West Haven, CT, USA
Food Drug Law J 61:585-622. 2006
- A history of drug advertising: the evolving roles of consumers and consumer protectionJulie Donohue
University of Pittsburgh, Graduate School of Public Health, Department of Health Policy and Management, 130 DeSoto Street, Crabtree Hall A613, Pittsburgh, PA 15261, USA
Milbank Q 84:659-99. 2006....
- Pharmaceutical marketing practices: balancing public health and law enforcement interests; moving beyond regulation-through-litigationChristopher D Zalesky
World Wide Health Care Compliance, Johnson and Johnson, USA
J Health Law 39:235-64. 2006..This approach borrows lessons learned from the FDA's efficient and effective regulatory and enforcement methods and maintains a careful balance between the interests of patient-beneficiaries, the government and industry...
- Privacy and policy for genetic researchJudith Wagner DeCew
Department of Philosophy, Clark University, 950 Main Street, Worcester, MA 01610, USA
Ethics Inf Technol 6:5-14. 2004....
- The federal preemption debate in pharmaceutical labeling product liability actionsJodie M Gross
Harris Beach PLLC, New York, New York, USA
Tort Trial Insur Pract Law J 43:35-70. 2007
- Balancing government regulation against access to drugs: address to Seton Hall University School of Law, February 16, 2007Daniel Meron
United States Department of Health and Human Services, USA
Seton Hall Law Rev 37:929-39. 2007
- Obesity--the new frontier of public health lawMichelle M Mello
Department of Health Policy and Management, Harvard School of Public Health, Boston, USA
N Engl J Med 354:2601-10. 2006
- Public health. A case study of personalized medicineS H Katsanis
Genetics and Public Policy Center, Berman Institute of Bioethics corrected, The Johns Hopkins University, Washington, DC 20036, USA
Science 320:53-4. 2008
- The pharmaceutical industry's responsibility for protecting human subjects of clinical trials in developing nationsFinnuala Kelleher
Columbia Journal of Law and Social Problems, Columbia University, USA
Columbia J Law Soc Probl 38:67-106. 2004....
- Bush tails follow-onsJeff Fox
Nat Biotechnol 26:366. 2008
- Ten years of judicial gatekeeping under DaubertJoe S Cecil
Federal Judicial Center s Program on Scientific and Technical Evidence, One Columbus Circle, NE, Washington, DC 20002, USA
Am J Public Health 95:S74-80. 2005..Future research should focus on the pretrial screening of expert testimony and interactions between the attorneys and experts in shaping that testimony...
- The need for FDA regulation of tobacco productsEdward M Kennedy
Yale J Health Policy Law Ethics 3:101-8. 2002
- Puppy love: bioterrorism, civil rights, and public healthGeorge J Annas
Health Law Department, Boston University School of Public Health, USA
Fla Law Rev 55:1171-90. 2003
- When terrorism threatens health: how far are limitations on personal and economic liberties justified?Lawrence O Gostin
Georgetown Univesity, Washington, DC, USA
Fla Law Rev 55:1105-70. 2003
- Nontherapeutic research with children: the virtues and vices of legal uncertaintyDavid M Smolin
Cumberland Law School, Samford University, USA
Cumberland Law Rev 33:621-45. 2002
- Molecular diagnostics: an FDA perspectiveAli M Ardekani
Department of Therapeutic Proteins, CBER, FDA, Bethesda, MD 20892, USA
Expert Rev Mol Diagn 3:129-40. 2003....
- Senators grill NIH director over restrictions on stem-cell researchJeffrey Brainard
Chron High Educ 49:A25. 2003
- America's other drug problem: how the drug industry distorts medicine and politicsArnold S Relman
Harvard Medical School, USA
New Repub 227:27-41. 2002
- Dipping into Uncle Sam's pockets: federal funding of stem cell research: is it legal?Carly Goldstein
Boston Univ Public Interest Law J 11:229-59. 2002
- Taking another look at the definition of an embryo: President Bush's criteria and the problematic application of federal regulations to human embryonic stem cellsSimon B Auerbach
Emory University School of Law, Atlanta, Georgia, USA
Emory Law J 51:1557-604. 2002
- Liability for institutional review boards: from regulation to litigationDavid B Resnik
The Brody School of Medicine at East Carolina University, Greenville, North Carolina, USA
J Leg Med 25:131-84. 2004
- Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugsLars Noah
University of Florida, P O Box 117625, Gainesville, FL 32611 7625, USA
S C Law Rev 54:371-403. 2002..Otherwise, patients may continue to lose access to important therapeutic products...
- Informed consent and investigational new drug abuses in the U.S. militaryMary L Cummings
Systems Engineering, University of Virginia, PO Box 400747, Charlottesville, VA 22904 4747, USA
Account Res 9:93-103. 2002....
- A comprehensive national policy to stop human cloning: an analysis of the Human Cloning Prohibition Act of 2001 with recommendations for federal and state legislaturesShawn E Peterson
Notre Dame Law School, USA
Notre Dame J Law Ethics Public Policy 17:217-68. 2003
- Experts warn drug industry, government about weaknesses in drug supply chainDonna Young
Am J Health Syst Pharm 60:2176, 2180, 2184. 2003
- Private wealth and public health: a critique of Richard Epstein's defense of the "old" public healthWilliam J Novak
Department of History, University of Chicago, 1126 East 59th Street, Chicago, IL 60637, USA
Perspect Biol Med 46:S176-98. 2003....
- Children in clinical research: a conflict of moral valuesVera Hassner Sharav
The Alliance for Human Research Protection
Am J Bioeth 3:W-IF 2. 2003....
- Cloning and stem cells--handicapping the political and scientific debatesGeorge Q Daley
Whitehead Institute for Biomedical Research, Cambridge, USA
N Engl J Med 349:211-2. 2003
- Clinical trials face heightened scrutiny as science and commerce appear to mergeAlvin J Lorman
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, USA
J Biolaw Bus 4:23-32. 2001..The risk of increased government involvement includes criminal prosecution of physicians for failing to follow the rules, as an innovative case in California demonstrates...
- Liberalism, communitarianism, and public health: comments on Lawrence O. Gostin's lectureWendy E Parmet
Northeastern University, USA
Fla Law Rev 55:1221-40. 2003
- A postmodernist take on the human embryo research debateLars Noah
University of Florida, USA
Conn Law Rev 36:1133-61. 2004
- Reflections of a forensic psychiatrist in Washington: politics and policyRenee L Binder
Psychiatry and the Law Program, University of California, San Francisco, CA, USA
J Am Acad Psychiatry Law 32:324-8. 2004
- Law's knowledge: science for justice in legal settingsSheila Jasanoff
John F Kennedy School of Government, School of Public Health, Department of the History of Science, Harvard University, 79 JFK Street, Room L354, Boston, MA, USA
Am J Public Health 95:S49-58. 2005..The important question for the law is not how judges can best do justice to science, but rather how courts can better render justice under conditions of uncertainty and ignorance...
- A cognitive scientist looks at DaubertGeorge P Lakoff
1203 Dwinelle Hall, University of California at Berkeley, Berkeley, CA 94720 2650, USA
Am J Public Health 95:S114-20. 2005..Daubert functions in its application as a strategic initiative that significantly moves America in a conservative direction, in the moral and political spheres, as well as in the legal sphere...
- Why Ashcroft is wrong on assisted suicideNelson Lund
George Mason University School of Law, USA
Commentary 113:50-5. 2002
- Protecting research subjects--the crisis at Johns HopkinsRobert Steinbrook
N Engl J Med 346:716-20. 2002
- Pharmacogenetics: ethical issues and policy optionsAllen Buchanan
Department of Philosophy, University of Arizona, Tucson, AZ, USA
Kennedy Inst Ethics J 12:1-15. 2002..We analyze each of these categories of ethical issues and provide policy approaches for addressing them...
- Ethics, regulation, and biomedical researchMatthew Weed
Yale University, USA
Kennedy Inst Ethics J 14:361-8. 2004....
- Politics, culture, and the lab: public attitudes toward animals and human embryonic stem cells have fostered different research agendas in Britain and the United StatesAnne Marie Borrego
Chron High Educ 51:A43-5. 2005
- The President's Council on Bioethics: my take on some of its deliberationsWilliam F May
Institute for Practical Bioethics and Public Life, University of Virginia, USA
Perspect Biol Med 48:229-40. 2005
- What has a decade of Daubert wrought?Margaret A Berger
Brooklyn Law School, 250 Joralemon Street, Room 911, Brooklyn, NY 11201, USA
Am J Public Health 95:S59-65. 2005..expert witnesses? What do we know about Daubert's impact on improving science in the court room? What has been Daubert's effect on access to the courts? Does Daubert further public policy objectives of protecting the public against harm?..
- Bioethical malpractice: risk and responsibilities in human researchBarbara A Noah
Health Law and Policy, University of Florida Levin College of Law, P O Box 117629, Gainesville, FL 32611 7629, USA
J Health Care Law Policy 7:175-241. 2004
- FDA and EMEA pool scientific adviceAlla Katsnelson
Nat Biotechnol 22:1490-1. 2004
- Safety in New Zealand's adventure tourism industry: the client accident experience of adventure tourism operatorsT A Bentley
Centre for Tourism Research, Department of Management and International Business, Massey University, Albany, New Zealand
J Travel Med 7:239-45. 2000..CONCLUSIONS: The prevalence of client injuries in activity sectors not presently covered by government regulation, suggests policy makers should look again at extending codes of practice to a wider range of adventure ..
- Creating an oversight infrastructure for electronic health record-related patient safety hazardsHardeep Singh
Houston VA Health Services Research and Development Center of Excellence, Texas, USA
J Patient Saf 7:169-74. 2011..Implementation of this proposed infrastructure can facilitate identification of EHR-related adverse events and errors and potentially create a safer and more effective EHR-based health care delivery system...
Research Grants204 found, 100 shown here
- SAFEHAVEN: Decision Support for Nursing Home Resident Disaster EvacuationsVincent Mor; Fiscal Year: 2010..Using existing nursing home data from multiple sources, this study seeks to understand the consequences of hurricanes and evacuation decisions, providing the first evidence base to inform the creation of evacuation guidelines. ..
- Views and Approaches Toward Research Integrity Among IRBsRobert Klitzman; Fiscal Year: 2007..smaller institutions. We anticipate that the data from this study will serve as a significant foundation in assisting future research and the improvement of Rl through guidelines, education and other capacity building. ..
- Views of Privacy of Genetic InformationRobert Klitzman; Fiscal Year: 2005..The findings of this study can enhance further policy, professional and public education, and future research in this area. ..
- Impact of Medicare Part D on Racial Disparities in Diabetes Treatment and OutcomeJulie Marie Donohue; Fiscal Year: 2010....
- Innovative Interventions for Smoking CessationDorothy K Hatsukami; Fiscal Year: 2010..The results of this study will provide useful information on directions to pursue to improve our pharmacotherapies and behavioral treatments and to better understand the various aspects of addiction. ..
- TREATMENT OF SMOKELESS TOBACCO USERSDorothy Hatsukami; Fiscal Year: 2005..The results of this study will determine the potential for an alternative and viable method for treating ST users. ..
- Novel Determinants and Measures of Smokeless Tobacco UseDorothy K Hatsukami; Fiscal Year: 2010..This study would demonstrate the feasibility and impact of switching ST users to less toxic ST products. Together, these studies will help to guide important policy decisions to reduce the toll of tobacco-related disease. ..
- Understanding the Adoption and Implementation of Tobacco-Free Regulation in SubstLillian T Eby; Fiscal Year: 2010..Thus, understanding the additive effects of the implementation of this top-down driven, restrictive, state-mandated regulation on clinicians has substantial individual health and health policy implications. ..
- Evaluating Low Ignition Propensity Cigarette LegislationRICHARD O CONNOR; Fiscal Year: 2007..Taken together, these studies comprise a comprehensive evaluation of the potential impacts of this harm-reduction policy, which will inform policymakers in other jurisdictions considering similar regulations. ..
- TOBACCO EXPOSURE REDUCTIONDorothy Hatsukami; Fiscal Year: 2007..The results of research from this TTURC will provide the scientific basis for urgent policy, public education, and regulatory efforts to reduce tobacco harm. ..
- Clinical Supervision and Turnover in Substance Abuse TxLILLIAN EBY; Fiscal Year: 2007..This project responds to program announcement PA-03-011 "Services Research in the National Drug Abuse CTN". Substance abuse treatment centers that are affiliated with the Clinical Trails Network will provide data for the project. ..
- Clinical Supervision and Turnover in Substance Abuse TxLILLIAN EBY; Fiscal Year: 2009..This project responds to program announcement PA-03-011 "Services Research in the National Drug Abuse CTN". Substance abuse treatment centers that are affiliated with the Clinical Trails Network will provide data for the project. ..
- Exploring current smokers? interest in using smokeless tobacco productsRICHARD O CONNOR; Fiscal Year: 2009..The set of studies may help to tease apart the various aspects of the price-product relationship and so better inform public policy debates. ..
- Understanding the Adoption and Implementation of Tobacco-Free Regulation in SubstLILLIAN EBY; Fiscal Year: 2009..Thus, understanding the additive effects of the implementation of this top-down driven, restrictive, state-mandated regulation on clinicians has substantial individual health and health policy implications. ..
- Evaluation of Oral Tobacco as a Harm Reduction Method for SmokersDorothy K Hatsukami; Fiscal Year: 2010..The results from these studies will help determine the effects and feasibility of using oral tobacco products as both a cessation aid and a method to reduce individual health risk in cigarette smokers. ..
- Exploring current smokers? interest in using smokeless tobacco productsRICHARD J O apos CONNOR; Fiscal Year: 2010..The set of studies may help to tease apart the various aspects of the price-product relationship and so better inform public policy debates. ..
- Research Integrity & Financial Conflicts of InterestPatricia Tereskerz; Fiscal Year: 2004..4) Explore the utility of using data reduction techniques and appropriate, multi-variate modeling techniques to show which types of financial arrangements predict questionable integrity practices. ..
- Interventions for Tobacco Dependent AdolescentsDorothy Hatsukami; Fiscal Year: 2005....
- Influence of Calorie Labeling on Food ChoiceBrian Elbel; Fiscal Year: 2010..Moreover, it will shed light on why the policy is effective or not. The long term goal is to build on this knowledge to develop effective public polices to combat obesity. ..
- Evaluating Low Ignition Propensity Cigarette LegislationRICHARD O CONNOR; Fiscal Year: 2009..Taken together, these studies comprise a comprehensive evaluation of the potential impacts of this harm-reduction policy, which will inform policymakers in other jurisdictions considering similar regulations. ..
- Novel Determinants and Measures of Smokeless Tobacco UseDorothy K Hatsukami; Fiscal Year: 2010..This study would demonstrate the feasibility and impact of switching ST users to less toxic ST products. Together, these studies will help to guide important policy decisions to reduce the toll of tobacco-related disease. ..
- Clinical Supervision and Turnover in Substance Abuse TxLillian T Eby; Fiscal Year: 2010..This project responds to program announcement PA-03-011 "Services Research in the National Drug Abuse CTN". Substance abuse treatment centers that are affiliated with the Clinical Trails Network will provide data for the project. ..
- Evaluation of Oral Tobacco as a Harm Reduction Method for SmokersDorothy Hatsukami; Fiscal Year: 2009..The results from these studies will help determine the effects and feasibility of using oral tobacco products as both a cessation aid and a method to reduce individual health risk in cigarette smokers. ..
- Innovative Interventions for Smoking CessationDorothy Hatsukami; Fiscal Year: 2009..The results of this study will provide useful information on directions to pursue to improve our pharmacotherapies and behavioral treatments and to better understand the various aspects of addiction. ..
- National Black Leadership Conference on GeneticsKathy Hudson; Fiscal Year: 2004..The Conference will be held in Washington DC in May 2004. ..
- NEWBORN GENETIC SCREENING:FOR WHOSE BENEFIT?Lainie Ross; Fiscal Year: 2005..OUTCOMES: The major outcomes will be a series of peer-reviewed articles and a full-length book entitled Newborn Genetic Screening: In whose Interest? For whose Benefit? ..
- Making Every Voice Count: Public Consultation on Genetics, Environment and HealthJoan Scott; Fiscal Year: 2007....
- Impact of Poor Health & AIDS on Small Businesses in SAMark Pauly; Fiscal Year: 2003..They will be useful for predicting the effect of changes in health on economic activity in this sector, and for allocating resources for disease prevention and treatment. ..
- Making Every Voice Count: Public Consultation on Genetics, Environment and HealthKathy Hudson; Fiscal Year: 2007..abstract_text> ..
- The Effect of Aflatoxin Regulation on Global Liver Cancer RiskFelicia Wu; Fiscal Year: 2010..While we focus on the impact of a harmonized aflatoxin standard on global liver cancer burden, the methodologies can be broadened to address standard-setting of other important carcinogens. ..
- Engineering of Vascularized BoneJeremy J Mao; Fiscal Year: 2010....
- Suicidality in Schizophrenia: Risk & Protective FactorsDEQUINCY LEZINE; Fiscal Year: 2004..abstract_text> ..
- State Policies and Hospitalizations from Nursing HomesVincent Mor; Fiscal Year: 2004..These theoretical insights will help shape the policy implications emerging from the study. ..
- Tracking stem cells in engineered tissue and organs in vivo and in real timeJeremy J Mao; Fiscal Year: 2010..It also has a potential to contribute to our understanding of the engineered osteochondral interface that is of critical value in bioengineered replacement of arthritic joints. ..
- Environmental Epidemiology in Community SettingsDavid Ozonoff; Fiscal Year: 2007..It also includes activities to enrich the experience of the trainees and promote social and professional cohesion. ..
- Stem Cell Based Soft Tissue ReconstructionJeremy Mao; Fiscal Year: 2009..An interdisciplinary team of biomedical engineers, biologists, biomaterial scientists, imaging scientists and surgical consultants have been assembled to meet the challenges of realizing our goals. ..
- SYNERGY OF HOST DEFENSE MECHANISMS IN LUNGArturo Casadevall; Fiscal Year: 2006..By comparing the immune response in Ab-permissive and Ab-non-permissive murine strains we will learn the conditions and mechanisms by which Ab-mediates protection against C. neoformans. ..
- Annotating functional sites in 3D biological structuresRUSS BIAGIO ALTMAN; Fiscal Year: 2010..In particular, we will focus our new capabilities on three difficult function annotation challenges: ATP binding sites, phosphorylation sites, and metabolizing enzyme active sites. ..
- Providers' perceptions of the diaphragm in Southern Afr*Cynthia Harper; Fiscal Year: 2005..As the diaphragm effectiveness results become available, data from this proposed study will position us to design counseling interventions and to address provider education and training needs. ..
- NATIONAL RESEARCH SERVICE AWARDVincent Mor; Fiscal Year: 2007....
- Community VOICES (2):Community VOICES on informed consent in emergency situationsLynne D Richardson; Fiscal Year: 2010..The entire toolkit will be made publicly available on the Mount Sinai EM website and will be actively disseminated to medical societies, governmental agencies, bioethics organizations &others. ..
- Stem-Cell Based Tissue Engineering in Regenerative Medicine ConferenceJeremy Mao; Fiscal Year: 2006..abstract_text> ..
- LONGITUDINAL ORAL HEALTH OUTCOMES IN HIGH-RISK ADULTSGREGG GILBERT; Fiscal Year: 2003....
- SITE-SPECIFIC MUTAGENESIS OF ISOMERASESGregory Petsko; Fiscal Year: 1990..Finally, mutations will be made at several other positions where the crystallographic results and sequence conservation imply a possible role in either active site architecture or catalysis: Ser 96, Cys 126, Glu 97, and Asn 10...
- ERYTHROCYTAPHERESIS TO LOWER IRON LOADING IN THALASSEMIAAlan Cohen; Fiscal Year: 2002....
- OUTCOMES OF HOSPITAL STAFFINGLinda Aiken; Fiscal Year: 1999....
- Effects of Dioxin on Vietnamese CiviliansDavid Carpenter; Fiscal Year: 2004..7. ..
- ARE FEDERAL REGULATIONS ON ALCOHOL USE SAFEJonathan Howland; Fiscal Year: 2001..The results of this study will provide information on the risks of hangovers for injury and may inform public policy on alcohol use in conjunction with commercial ship operation. ..
- FREE PLASMA SEX HORMONE AND ANDROGEN ACTIONRobert Rosenfield; Fiscal Year: 1980..The hypothesis that LH is insensitive to modest decrements of plasma testosterone will be tested by acutely lowering plasma testosterone levels in normal volunteers with aminoglutethimide...